| 0001A |
HC ADM PFIZER SARSCOV2 30MCG/0.3ML 1ST |
|
| 0001A |
HC ADMIN SARSCOV2 30MCG/0.3ML DOSE 1 |
|
| 0001A |
Adm sarscov2 30mcg/0.3ml 1st |
|
| 0002A |
HC ADM PFIZER SARSCOV2 30MCG/0.3ML 2ND |
|
| 0002A |
HC ADMIN SARSCOV2 30MCG/0.3ML DOSE 2 |
|
| 0002A |
Adm sarscov2 30mcg/0.3ml 2nd |
|
| 0011A |
HC ADM MODERNA SARSCOV2 100MCG/0.5ML1ST |
|
| 0011A |
HC ADMIN SARSCOV2 100MCG/0.5ML DOSE 1 |
|
| 0011A |
Adm sarscov2 100mcg/0.5ml1st |
|
| 0012A |
HC ADM MODERNA SARSCOV2 100MCG/0.5ML2ND |
|
| 0012A |
HC ADMIN SARSCOV2 100MCG/0.5ML DOSE 2 |
|
| 0012A |
Adm sarscov2 100mcg/0.5ml2nd |
|
| 0202U |
NFCT DS BCT/VIR RESPIR DNA/RNA 22 TRGT SARSCOV2 |
|
| 0225U |
Nfct ds dna&rna 21 sarscov2 |
INFECTIOUS DISEASE (BACTERIAL OR VIRAL RESPIRATORY TRACT INFECTION) PATHOGEN-SPECIFIC DNA AND RNA, 21 TARGETS, INCLUDING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2), AMPLIFIED PROBE TECHNIQUE |
| 0226U |
Svnt sarscov2 elisa plsm srm |
SURROGATE VIRAL NEUTRALIZATION TEST (SVNT), SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]), ELISA, PLASMA, SERUM |
| 0226U |
SUROGAT VIR NEUTRLZJ TST SARSCOV2 ELISA PLSM SRM |
|
| 87636 |
SARSCOV2 & INFAB AMP PR |
|
| 87637 |
SARSCOV2&INFAB&RSV AMP P |
|
| 86328 |
IA NFCT AB SARSCOV2 COVID19 |
|
| 86408 |
NEUTRLZG ANTB SARSCOV2 SCR |
NEUTRALIZING ANTIBODY, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID19]); SCREEN |
| 86409 |
NEUTRLZG ANTB SARSCOV2 TITER |
NEUTRALIZING ANTIBODY, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID19]); TITER |
| 87636 |
IADNA SARSCOV2& INF A&B MULT AMPLIFIED PROBE TQ |
|
| 87637 |
HC SARSCOV2 & INF A&B & RSV AMP PRB |
|
| 87637 |
SARSCOV2 & INF A&B & RSV AMP PRB |
|
| 91300 |
SARSCOV2 VAC 30MCG/0.3ML IM |
|
| 91301 |
SARSCOV2 VAC 100MCG/0.5ML IM |
|
| 87636 |
Sarscov2 & Inf A&b Amp Prb |
|
| 90480 |
HC IMM ADMN SARSCOV2 VACCINE SINGLE DOSE |
|
| 91302 |
SARSCOV2 VAC 5X1010VP/.5MLIM |
|
| 91303 |
SARSCOV2 VAC AD26 .5ML IM |
|